David Ferreira Shares 3 Pillars of Patient Blood Management
David Ferreira, Director of the Immuno-hemotherapy Service at ULSGE at Gaia and Espinho Local Health Unit, shared on LinkedIn:
”Patient Blood Management (PBM) is a structured clinical approach that seeks to optimize the patient’s hematological status, reduce avoidable blood loss, and ensure that transfusions are only used when truly necessary.
Its strength comes from these three pillars:
- Optimize erythropoiesis — Diagnose and treat anemia before invasive procedures or in chronic patients;
- Minimize blood loss — Surgical, anesthetic, and laboratory strategies with less waste;
- Improve tolerance to anemia — Make individualized transfusion decisions, avoiding unnecessary transfusions.
The benefits are clear:
- Fewer avoidable transfusions
- Fewer complications
- Better recovery
- Responsible use of a scarce resource
At the Gaia and Espinho Local Health Unit, even in a context of great pressure on the Immuno-Hemotherapy Service, we hold regular PBM consultations every week, reinforcing our commitment to our patients.
This work is only possible thanks to the dedication of our medical and nursing teams in our small Day Hospital, who ensure a continuous and technically demanding response.
PBM is not just a technique—it is a culture of safety, quality, and respect for patients and donors.
And it lives on at ULSGE.
We continue, with rigor and resilience.”

Stay updated with Hemostasis Today.
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke